I Mab Stock Performance
| IMAB Stock | USD 0.94 0.02 2.08% |
The firm retains a Market Volatility (i.e., Beta) of 1.56, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, I Mab will likely underperform. At this point, I Mab has a negative expected return of -0.37%. Please make sure to check out I Mab's total risk alpha, skewness, rate of daily change, as well as the relationship between the maximum drawdown and accumulation distribution , to decide if I Mab performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days I Mab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | I-MAB Q2 2024 Earnings Call Transcript Highlights Strategic Shifts and Financial Resilience | 08/29/2024 |
2 | I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024 | 09/16/2024 |
3 | I-MAB Appoints New Board Member and Audit Committee - TipRanks | 09/23/2024 |
4 | IMAB Stock Dips Over 5 percent Amidst Mixed Financial Performance | 10/21/2024 |
5 | I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024 | 10/30/2024 |
6 | I-Mab Trading 3.7 percent Higher Heres Why | 11/06/2024 |
7 | I-Mab to Participate at the Piper Sandler Healthcare Conference | 11/21/2024 |
| Begin Period Cash Flow | 3.3 B |
IMAB |
I Mab Relative Risk vs. Return Landscape
If you would invest 130.00 in I Mab on August 25, 2024 and sell it today you would lose (36.00) from holding I Mab or give up 27.69% of portfolio value over 90 days. I Mab is currently does not generate positive expected returns and assumes 5.3889% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than IMAB, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
I Mab Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for I Mab's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as I Mab, and traders can use it to determine the average amount a I Mab's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0682
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMAB |
Estimated Market Risk
| 5.39 actual daily | 47 53% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average I Mab is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of I Mab by adding I Mab to a well-diversified portfolio.
I Mab Fundamentals Growth
IMAB Stock prices reflect investors' perceptions of the future prospects and financial health of I Mab, and I Mab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IMAB Stock performance.
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.29 | ||||
| Operating Margin | (49.38) % | ||||
| Current Valuation | (102.45 M) | ||||
| Shares Outstanding | 77.58 M | ||||
| Price To Book | 0.36 X | ||||
| Price To Sales | 22.38 X | ||||
| Revenue | 27.64 M | ||||
| Gross Profit | 41.59 M | ||||
| EBITDA | (1.21 B) | ||||
| Net Income | (206.77 M) | ||||
| Cash And Equivalents | 3.92 B | ||||
| Cash Per Share | 47.20 X | ||||
| Total Debt | 18.89 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 7.31 X | ||||
| Book Value Per Share | 2.91 X | ||||
| Cash Flow From Operations | (1.3 B) | ||||
| Earnings Per Share | (2.16) X | ||||
| Market Capitalization | 85.74 M | ||||
| Total Asset | 2.61 B | ||||
| Retained Earnings | (8.33 B) | ||||
| Working Capital | 1.92 B | ||||
| Current Asset | 1.51 B | ||||
| Current Liabilities | 527.75 M | ||||
About I Mab Performance
By analyzing I Mab's fundamental ratios, stakeholders can gain valuable insights into I Mab's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if I Mab has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if I Mab has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -1.2 K | -1.2 K | |
| Return On Tangible Assets | (0.59) | (0.62) | |
| Return On Capital Employed | (0.56) | (0.59) | |
| Return On Assets | (0.56) | (0.59) | |
| Return On Equity | (6.05) | (5.74) |
Things to note about I Mab performance evaluation
Checking the ongoing alerts about I Mab for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for I Mab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| I Mab generated a negative expected return over the last 90 days | |
| I Mab has high historical volatility and very poor performance | |
| I Mab has some characteristics of a very speculative penny stock | |
| I Mab has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 27.64 M. Net Loss for the year was (206.77 M) with profit before overhead, payroll, taxes, and interest of 41.59 M. | |
| I Mab currently holds about 3.92 B in cash with (1.3 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| I Mab has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: I-Mab to Participate at the Piper Sandler Healthcare Conference |
- Analyzing I Mab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether I Mab's stock is overvalued or undervalued compared to its peers.
- Examining I Mab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating I Mab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of I Mab's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of I Mab's stock. These opinions can provide insight into I Mab's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for IMAB Stock analysis
When running I Mab's price analysis, check to measure I Mab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy I Mab is operating at the current time. Most of I Mab's value examination focuses on studying past and present price action to predict the probability of I Mab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move I Mab's price. Additionally, you may evaluate how the addition of I Mab to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |